Ignite Creation Date:
2025-12-25 @ 12:20 AM
Ignite Modification Date:
2026-02-25 @ 4:15 AM
Study NCT ID:
NCT02287558
Status:
COMPLETED
Last Update Posted:
2020-07-15
First Post:
2014-11-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pomalidomide in Hereditary Hemorrhagic Telangiectasia and Transfusion-Dependent Vascular Ectasia: a Phase I Study
Sponsor:
The Cleveland Clinic
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CASE4Z14
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None